Ekso Bionics Holdings, Inc. (EKSO)
Market Cap | 22.02M |
Revenue (ttm) | 18.16M |
Net Income (ttm) | -12.42M |
Shares Out | 21.59M |
EPS (ttm) | -0.78 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 9,994 |
Open | 1.020 |
Previous Close | 1.030 |
Day's Range | 1.010 - 1.040 |
52-Week Range | 0.690 - 3.129 |
Beta | 1.46 |
Analysts | Strong Buy |
Price Target | 6.25 (+512.75%) |
Earnings Date | Oct 24, 2024 |
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The com... [Read more]
Financial Performance
In 2023, Ekso Bionics Holdings's revenue was $18.28 million, an increase of 41.57% compared to the previous year's $12.91 million. Losses were -$15.20 million, 0.78% more than in 2022.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for EKSO stock is "Strong Buy." The 12-month stock price forecast is $6.25, which is an increase of 512.75% from the latest price.
News
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering
SAN RAFAEL, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industr...
Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2024 Earnings Conference Call July 29, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo...
Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
SAN RAFAEL, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industr...
Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...
Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso's Board
Artificial Intelligence in the Global Prosthetic Market 2024-2033, with Profiles of Ossur, Blatchford, Ottobock, Ekso Bionics, Open Bionics, Advanced Arm Dynamics and BrainRobotics
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Prosthetic Market - A Global and Regional Analysis: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMark...
Ekso Indego Personal to be Featured on ‘Health Uncensored' with Dr. Drew Pinsky
Segment to appear on Fox Business News on Sunday, May 12 at 5:30 p.m. ET SAN RAFAEL, Calif.
Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Results Conference Call April 29, 2023 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo...
Ekso Bionics Announces First Quarter 2024 Financial Results
SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and indust...
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
SAN RAFAEL, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today an...
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
SAN RAFAEL, Calif., April 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and indust...
Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo...
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskelet...
Ekso Bionics Launches GaitCoach Software for EksoNR
SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29
SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Compa...
Ekso Bionics Holdings, Inc. (EKSO) Q3 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2023 Earnings Call October 26, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Scott Davis - Chief Executive Officer Jason Jones ...
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
SAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today rep...
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
SAN RAFAEL, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today an...
Ekso Bionics Holdings, Inc. (EKSO) Q2 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q2 2023 Results Conference Call July 27, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Scott Davis - Chief Executive Officer Jason...
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
SAN RAFAEL, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industr...
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript.
Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
Highest Quarterly Revenues in Company History SAN RAFAEL, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in...